Mpharma
9 known investors
mPharma operates a network of pharmacies across Africa that uses technology to negotiate lower drug prices with manufacturers and manage prescription information and payments.
Investors · 9
4DX VenturesAccra · $50K – $500K
Breyer CapitalAustin · $500K – $10M
OTVNew York
Peregrine VenturesOr Yehuda · $500K – $3M
The Raba PartnershipCape Town · $50K – $5M
Timon CapitalLagos · $100K – $250K
Jam FundreportedLos Angeles · $500K – $20Mvia Justin Mateen · inferred
Musha VenturesreportedSeattle · $25K – $500K
Novastar VenturesreportedLondon
Founder mafia
2 people who came through Mpharma went on to found or lead other companies.
Competitors · 2
by search overlapMirum Pharmaceuticals11 shared keywordsMirum Pharmaceuticals is a biopharmaceutical company that develops and delivers therapies for people living with rare diseases. It operates in the U.S. and Europe, engaging with healthcare professionals, patients, and payers within applicable regulatory frameworks.
Madrigal8 shared keywordsMadrigal is a biopharmaceutical company developing therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious progressive liver disease. Its research led to the first FDA-approved treatment for MASH, aimed at halting or reversing liver fibrosis before cirrhosis develops.
Companies competing with Mpharma for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Mpharma do?
- mPharma operates a network of pharmacies across Africa that uses technology to negotiate lower drug prices with manufacturers and manage prescription information and payments.
- Who are Mpharma's investors?
- Mpharma's investors include 4DX Ventures, Breyer Capital, OTV, Peregrine Ventures, The Raba Partnership, Timon Capital, Jam Fund, Musha Ventures and 1 more.